Human microbiota-transplanted C57BL/6 mice and offspring display reduced establishment of key bacteria and reduced

Randi Lundberg1,2,3, Martin F Toft4,5, Stine B Metzdorff6

  • 1Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 1871, Frederiksberg C, Denmark. lundberg.randi@gmail.com.

Scientific Reports
|May 10, 2020
PubMed

Insights

Transplanting human microbiota into germ-free mice poorly stimulates their immune system, losing key bacteria. Murine microbiota better colonizes mice, highlighting differences in host-microbe interactions.

Area of Science:

  • Microbiome research
  • Immunology
  • Host-microbe interactions

Background:

  • Germ-free (GF) mice transplanted with microbiota exhibit distinct immune responses based on the donor source (human vs. murine).
  • Understanding these differences is crucial for designing accurate microbiota transplantation studies.

Purpose of the Study:

  • To compare the engraftment and immune-stimulating capacity of human versus murine microbiota in GF mice.
  • To assess the impact of microbiota source on host immune gene expression and plasma cytokine profiles.

Main Methods:

  • Germ-free C57BL/6 mice were colonized with either human or C57BL/6 murine microbiota.
  • Operational Taxonomic Units (OTUs) establishment and gene expression (immune-related, intestinal barrier) were analyzed.
  • Plasma cytokines and chemokines were quantified.

Main Results:

  • Lower engraftment (56%) of human OTUs compared to murine OTUs (81%) was observed.
  • Key anti-inflammatory human bacteria (e.g., Faecalibacterium, Bifidobacterium) failed to colonize.
  • Human microbiota recipients showed lower immune gene expression and altered cytokine profiles compared to murine microbiota recipients.

Conclusions:

  • Human microbiota transplantation to mice results in the loss of crucial immune-modulating bacteria.
  • The established human microbiota acts as a weak stimulator of the murine immune system.
  • Significant differences exist in host immune response to human versus murine microbiota, impacting study design.